Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents
Journal of Oncology Pharmacy Practice · 25.05.2026
DOI: 10.1177/10781552261448813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 25.05.2026. Verfasst von Jermaine Coward und 1 weiteren Autor:innen. Beteiligte Einrichtung: Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia. Die Arbeit nennt 6 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To assess patient-reported compliance with calcium and vitamin D supplementation and identify barriers in oncology patients prescribed bone resorptive therapy.
Methods
A multicentre observational study was conducted across several private day oncology infusion units within Australia. Adult cancer patients receiving denosumab, pamidronate, or zoledronic acid were identified. Eligible patients (excluding those with pre-existing osteoporosis or hypercalcaemia of malignancy) completed a 13-item survey including the MMAS-8 adherence scale. Clinical data were extracted from the CHARM prescribing system. Descriptive and comparative analyses were performed.
Results
80 people participated. 45% were reported being prescribed calcium and vitamin D supplements; 46.25% denied supplementation and 9% were unsure. Among prescribed patients, the mean MMAS-8 score was 6.86, indicating medium adherence. Hypocalcaemia occurred in 27.5% of patients, 60% of whom reported no supplementation. Vitamin D levels were unavailable in 55% of cases.
Conclusion
Under-prescribing and poor monitoring of calcium and vitamin D supplements are prevalent. Systematic supplementation protocols and pharmacist-led education could improve adherence and reduce skeletal-related complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia.
- Pharmacy - Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia.
ORCID-Profile: Jermaine Coward, Ashleigh Kate Smith
Zitieren
APA
Coward, J., & Smith, A. K. (2026). Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261448813
Vancouver
Coward J, Smith AK. Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261448813
BibTeX
@article{Coward2026,
author = {Coward, Jermaine and Smith, Ashleigh Kate},
title = {Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents},
journal = {Journal of Oncology Pharmacy Practice},
year = {2026},
doi = {10.1177/10781552261448813}
}
EUVIMED